21 Recruiting Studies Using Degarelix
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Degarelix
REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer
📍 Columbia University Irving Medical Center — New York, New York
Prostate Cancer Metastatic
View Study & Checklist ➔Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer
📍 M D Anderson Cancer Center — Houston, Texas
Prostate Adenocarcinoma
View Study & Checklist ➔Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer
📍 University of Wisconsin Carbone Cancer Center — Madison, Wisconsin
Prostate Cancer
View Study & Checklist ➔Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer
📍 University of California, Los Angeles — Los Angeles, California
Prostate Cancer
View Study & Checklist ➔A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Castration-Resistant Prostate Carcinoma
View Study & Checklist ➔Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial
📍 Fairbanks Memorial Hospital — Fairbanks, Alaska
Prostate Adenocarcinoma
View Study & Checklist ➔Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Prostate Adenocarcinoma
View Study & Checklist ➔Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)
📍 Winship Cancer Institute, Emory University — Atlanta, Georgia
Prostate Cancer
View Study & Checklist ➔Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Leukemia
View Study & Checklist ➔Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
📍 City of Hope Medical Center — Duarte, California
Prostate Adenocarcinoma
View Study & Checklist ➔Study of Radiation Therapy in Combination With Darolutamide + Degarelix in Intermediate Risk Prostate Cancer
📍 UHN Princess Margaret Hospital — Toronto, Ontario
Prostate Cancer
View Study & Checklist ➔ETHAN - ET for Male BC
📍 Georgetown University Medical Center — Washington D.C., District of Columbia
Male Breast Cancer
View Study & Checklist ➔Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
📍 VA Long Beach Healthcare System, Long Beach, CA — Long Beach, California
Prostate Cancer
View Study & Checklist ➔Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT
📍 Miami Cancer Institute at Baptist Health, Inc. — Miami, Florida
Prostate Cancer
View Study & Checklist ➔Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
📍 City of Hope Medical Center — Duarte, California
Castration-Sensitive Prostate Carcinoma
View Study & Checklist ➔Cardiometabolic Consequences of the Loss of Ovarian Function
📍 University of Colorado Anschutz Medical Campus — Aurora, Colorado
Menopause
View Study & Checklist ➔Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer
📍 M D Anderson Cancer Center — Houston, Texas
Prostate Cancer
View Study & Checklist ➔Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Biochemically Recurrent Prostate Carcinoma
View Study & Checklist ➔Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
Castration Levels of Testosterone
View Study & Checklist ➔A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
Prostate Cancer
View Study & Checklist ➔Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
📍 Mayo Clinic in Arizona — Phoenix, Arizona
Recurrent Castration-Sensitive Prostate Carcinoma
View Study & Checklist ➔